Supplementary Table 1 - Gene Expression from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance

Supplementary Table 1 - Gene Expression from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance

<p>Gene Expression-RNAseq. Summary gene expression data of the individual tumors included in Fig. 5a-c.</p>

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Renzo Perales-Linares (17314863) (author)
Andere auteurs:	Nektaria Maria Leli (17314866) (author), Hesham Mohei (17314869) (author), Silvia Beghi (17314872) (author), Osvaldo D. Rivera (17314875) (author), Nektarios Kostopoulos (17314878) (author), Andrea Giglio (17314881) (author), Subin S. George (17314884) (author), Mireia Uribe-Herranz (17314887) (author), Francesca Costabile (17314890) (author), Stefano Pierini (17314893) (author), Sergei Pustylnikov (17314896) (author), Giorgos Skoufos (14865857) (author), Yoseph Barash (15130157) (author), Artemis G. Hatzigeorgiou (17314899) (author), Constantinos Koumenis (14865905) (author), Amit Maity (17314902) (author), Michael T. Lotze (14937723) (author), Andrea Facciabene (17314905) (author)
Gepubliceerd in:	2025
Onderwerpen:	Cancer Tumor Biology Immuno-oncology Immunology Tumor resistance to immune response Immunotherapy Combination immunotherapy Progression, Invasion & Metastasis Tumor progression
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Supp. Figure 1 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
door: Renzo Perales-Linares (17314863)
Gepubliceerd in: (2025)

Supp. Figure 2 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
door: Renzo Perales-Linares (17314863)
Gepubliceerd in: (2025)

Supp. Figure 3 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
door: Renzo Perales-Linares (17314863)
Gepubliceerd in: (2025)

Supp. Figure 4 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
door: Renzo Perales-Linares (17314863)
Gepubliceerd in: (2025)

Supp. Figure 5 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
door: Renzo Perales-Linares (17314863)
Gepubliceerd in: (2025)

Supp. Figure 6 from Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
door: Renzo Perales-Linares (17314863)
Gepubliceerd in: (2025)

Figure S1 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
door: Xiaodong Shu (16721586)
Gepubliceerd in: (2025)

Figure S2 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
door: Xiaodong Shu (16721586)
Gepubliceerd in: (2025)

Figure S3 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
door: Xiaodong Shu (16721586)
Gepubliceerd in: (2025)

Figure S4 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
door: Xiaodong Shu (16721586)
Gepubliceerd in: (2025)

Figure S5 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
door: Xiaodong Shu (16721586)
Gepubliceerd in: (2025)

Figure S6 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
door: Xiaodong Shu (16721586)
Gepubliceerd in: (2025)

Figure S7 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
door: Xiaodong Shu (16721586)
Gepubliceerd in: (2025)

Table S1-S9 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
door: Xiaodong Shu (16721586)
Gepubliceerd in: (2025)

Supplementary Tables S2-13 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
door: Francisco Hermida-Prado (14958909)
Gepubliceerd in: (2025)

Supplementary Tables from MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages
door: Renumathy Dhanasekaran (14962092)
Gepubliceerd in: (2025)

Supplementary Table1 from USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer
door: Yidan Ren (14845140)
Gepubliceerd in: (2025)

Supplementary Table2 from USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer
door: Yidan Ren (14845140)
Gepubliceerd in: (2025)

Supplementary Table3 from USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer
door: Yidan Ren (14845140)
Gepubliceerd in: (2025)

Supplementary Table 7_Genes identified by differential expression analysis in pro vs non metastatic clones from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
door: Niccolò Roda (16437288)
Gepubliceerd in: (2025)

Figure S.1 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
door: Xufeng Lu (14960724)
Gepubliceerd in: (2025)

Figure S.2 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
door: Xufeng Lu (14960724)
Gepubliceerd in: (2025)

Figure S.3 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
door: Xufeng Lu (14960724)
Gepubliceerd in: (2025)

Figure S.4 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
door: Xufeng Lu (14960724)
Gepubliceerd in: (2025)

Figure S.5 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
door: Xufeng Lu (14960724)
Gepubliceerd in: (2025)

Figure S.6 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
door: Xufeng Lu (14960724)
Gepubliceerd in: (2025)

Figure S.7 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
door: Xufeng Lu (14960724)
Gepubliceerd in: (2025)

Figure S.8 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
door: Xufeng Lu (14960724)
Gepubliceerd in: (2025)

Supplementary Table 6_Gene modules analysis_GO and curated pathways associated to gene modules from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
door: Niccolò Roda (16437288)
Gepubliceerd in: (2025)

Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma
door: Isha Mondal (16721699)
Gepubliceerd in: (2025)

Supplementary Figure S1 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
door: Carlotta Antoniotti (15352506)
Gepubliceerd in: (2025)

Supplementary Figure S2 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
door: Carlotta Antoniotti (15352506)
Gepubliceerd in: (2025)

Supplementary Figure S3 from An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
door: Carlotta Antoniotti (15352506)
Gepubliceerd in: (2025)

Supplementary Table 9_Pro metastatic pathways identified by differential expression singlePT setting from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
door: Niccolò Roda (16437288)
Gepubliceerd in: (2025)

Figure 1 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
door: Massimiliano Mellone (14959419)
Gepubliceerd in: (2025)

Figure 2 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
door: Massimiliano Mellone (14959419)
Gepubliceerd in: (2025)

Figure 3 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
door: Massimiliano Mellone (14959419)
Gepubliceerd in: (2025)

Figure 4 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
door: Massimiliano Mellone (14959419)
Gepubliceerd in: (2025)

Figure 5 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
door: Massimiliano Mellone (14959419)
Gepubliceerd in: (2025)

Figure 6 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
door: Massimiliano Mellone (14959419)
Gepubliceerd in: (2025)

Cannot write session to /tmp/vufind_sessions/sess_bll3649b8ahk03oac71o4qnj08